Date: 16-19 September 2019

Venue: Royal Free London – Prof Chris Denton and Dr Voon Ong

Venue: Royal Hallamshire Hospital, Sheffield – Dr Mohammed Akil

Deadline: 19 July 2019

The Scleroderma Fellowship provides hands-on clinical experience across a four day programme, delivered by leading experts in the management of scleroderma at nationally-recognised specialised centres.

By the end of the fellowship, you will have increased your knowledge and skills in:

  • Undertaking comprehensive clinical assessment of scleroderma cases (including Modified Rodnan score and practical use of microvascular diagnostics)

  • Multi-speciality management and treatment initiation and follow-up and the role of specialist nurses

  • Assessing and managing cardiac, respiratory, renal, skin and gastrointestinal involvement and severe digital vascular disease

  • Recent clinical trials and emerging therapy

  • Understanding the treatment options for severe progressive disease including the use of Autologous Haematopoietic Stem Cell transplantation

  • Assessing patients with systemic sclerosis

  • Assessing and managing Rayanud’s and digital ulcers

  • Assessing and screening for cardiac and pulmonary complications

  • Screening for pulmonary hypertension

  • Setting up combined clinics

  • Selecting patients for stem cell transplant

Apply for the Fellowship


Apply now

Applicant information

Who can apply?

  • Fellowships are open to all members working and implementing practice in the UK and Northern Ireland only. They are recommended for those in senior years of specialist training and newly appointed consultants, although members from all professional backgrounds are eligible to apply

  • Applicants may apply for more than one fellowship, but if you are successfully chosen to participate in a fellowship you are no longer eligible to apply for further fellowships for two years from the start date of your successful fellowship.

How to apply

To be eligible for this fellowship applicants must submit:

  • A completed application form

  • A two-page CV (If you submit a CV that exceeds two pages, the first two pages only will be sent to the reviewing panel)

Applications should be submitted by Friday 19 July 2019. Any applications received after this deadline will not be accepted. You can see the status of your application by logging into ‘My BSR’. The application will not have submitted successfully unless the status shows as ‘complete’.

Reviewing process

A panel made up of a minimum of four people individually review the covering letter and CV of each application. These are numerically scored against criteria of suitability, based on skills and experience to date, and ability and/or plans to disseminate their learning. Following this, all applications are ranked according to their total score and the panel agree who to award the fellowships to.

Applying for leave

We will always aim to inform you of your success to allow you enough time to book study leave, but we would advise provisionally booking study leave at the time of applying for the fellowship to avoid disappointment.

If you have any questions or require further information, email the events team or call 020 7842 0900.


16-17 September 2019

Royal Free, London

Includes overview of Schleroderma management and tackling vasculopathy

Setting up a service and overview of scleroderma management

Overview of management of systemic sclerosis

Scleroderma specialist nursing service

Tackling vasculopathy in systemic sclerosis

Dermatology for scleroderma patients

Surgical treatments in scleroderma

Setting up a microvascular service for scleroderma

Case-based discussions

Developing a CMR service in CTD scleroderma

Scleroderma data collection and clinical research

Collaborative gastrointestinal service in scleroderma

Clinical trials in scleroderma

18-19 September 2019

Royal Hallamshire Hospital

Includes cardio-pulmonary complications and hypertension

Scleroderma: how do we measure it? Organ specific and comprehensive clinical scores

Assessment and management of Raynaud’s and digital ischaemia related to scleroderma

Cardio-pulmonary complications

Pulmonary hypertension: screening and management

Role of autologous haemopoietic stem cell transplant in scleroderma

Programme and speakers are subject to change.